141 related articles for article (PubMed ID: 29688911)
41. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
42. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
43. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.
Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH
Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781
[TBL] [Abstract][Full Text] [Related]
44. Role of transient receptor potential vanilloid subtype 2 in lower oesophageal sphincter in rat acid reflux oesophagitis.
Matsumoto K; Suenaga M; Mizutani Y; Matsui K; Yoshida A; Nakamoto T; Kato S
J Pharmacol Sci; 2021 Jul; 146(3):125-135. PubMed ID: 34030795
[TBL] [Abstract][Full Text] [Related]
45. Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study.
Matsumura T; Hashimoto H; Sekimizu M; Saito AM; Motoyoshi Y; Nakamura A; Kuru S; Fukudome T; Segawa K; Takahashi T; Tamura T; Komori T; Watanabe C; Asakura M; Kimura K; Iwata Y
Orphanet J Rare Dis; 2022 May; 17(1):201. PubMed ID: 35578298
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylase inhibition has cardiac and vascular protective effects in rats with pressure overload cardiac hypertrophy.
Jung H; Lee E; Kim I; Song JH; Kim GJ
Physiol Res; 2019 Oct; 68(5):727-737. PubMed ID: 31424255
[TBL] [Abstract][Full Text] [Related]
47. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
48. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
49. Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart.
Hofmann F; Fabritz L; Stieber J; Schmitt J; Kirchhof P; Ludwig A; Herrmann S
Cardiovasc Res; 2012 Aug; 95(3):317-26. PubMed ID: 22652004
[TBL] [Abstract][Full Text] [Related]
50. Lysophosphatidylcholine-induced cytotoxicity in osteoblast-like MG-63 cells: involvement of transient receptor potential vanilloid 2 (TRPV2) channels.
Fallah A; Pierre R; Abed E; Moreau R
Mol Membr Biol; 2013; 30(5-6):315-26. PubMed ID: 23964684
[TBL] [Abstract][Full Text] [Related]
51. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
[TBL] [Abstract][Full Text] [Related]
52. Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) Inhibitor Attenuates Amyloid β-Induced Cognitive Impairment: Possible Mechanisms.
Thapak P; Bishnoi M; Sharma SS
Neuromolecular Med; 2022 Jun; 24(2):183-194. PubMed ID: 34231190
[TBL] [Abstract][Full Text] [Related]
53. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
54. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
[TBL] [Abstract][Full Text] [Related]
55. The role of transient receptor potential vanilloid 2 channel in cardiac aging.
Jones S; Mann A; Worley MC; Fulford L; Hall D; Karani R; Jiang M; Robbins N; Rubinstein J; Koch SE
Aging Clin Exp Res; 2017 Oct; 29(5):863-873. PubMed ID: 27804106
[TBL] [Abstract][Full Text] [Related]
56. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.
Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A
Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457
[TBL] [Abstract][Full Text] [Related]
57. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
Huang W; Rubinstein J; Prieto AR; Wang DH
J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
[TBL] [Abstract][Full Text] [Related]
58. Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.
Abbadi D; Laroumanie F; Bizou M; Pozzo J; Daviaud D; Delage C; Calise D; Gaits-Iacovoni F; Dutaur M; Tortosa F; Renaud-Gabardos E; Douin-Echinard V; Prats AC; Roncalli J; Parini A; Pizzinat N
Cardiovasc Res; 2018 Jan; 114(1):123-137. PubMed ID: 29136112
[TBL] [Abstract][Full Text] [Related]
59. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
[TBL] [Abstract][Full Text] [Related]
60. Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
Chen A; Li W; Chen X; Shen Y; Dai W; Dong Q; Li X; Ou C; Chen M
BMC Cardiovasc Disord; 2016 Nov; 16(1):225. PubMed ID: 27855650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
